Genetic factors in metastatic progression of cutaneous melanoma: The future role of circulating melanoma cells in prognosis and management

Clinical and Experimental Metastasis

Volumn 28, Issue 4, 2011, Pages 327-336

  Ireland, A ^a   Millward, M ^a   Pearce, R ^b   Lee, M ^a   Ziman, M ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Circulating cells; Markers of disease progression; Melanoma; Metastasis; Patient monitoring

Indexed keywords

B RAF KINASE; CANCER VACCINE; DACARBAZINE; INTERLEUKIN 2; MELAN A; MELANOMA ANTIGEN 3; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MULTIDRUG RESISTANCE PROTEIN 5; PLX 4032; TYROSINE;

CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RESISTANCE; CANCER RISK; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; DRUG EFFICACY; HEREDITY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOGENESIS; MELANOMA; MELANOMA CELL; METASTASIS; OUTCOME ASSESSMENT; PHENOTYPE; PROGNOSIS; REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

DISEASE PROGRESSION; HUMANS; MELANOMA; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; SKIN NEOPLASMS;

EID: 79955524790     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9368-2     Document Type: Review

References (120)

1. TB Lewis, et al. 2005 Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction Cancer 104 1678 1686 16116595 1:CAS:528:DC%2BD2MXhtF2nt7rI (Pubitemid 41437431)
2. Australasian Association of Cancer Registries (2006) Australian Institute of Health and Welfare. http://www.aihw.gov.au/cancer/aacr/. Cited 28/4/10
3. A Jack, et al. 2006 The treatment of melanoma with an emphasis on immunotherapeutic strategies Surg Oncol 15 13 24 16815006 (Pubitemid 44404070)
4. RT Lee, et al. 2008 Melanoma presenting as circulating tumor cells associated with failed angiogenesis Melanoma Res 18 289 294 18626315 1:CAS:528:DC%2BD1MXkslGrs7s%3D
5. B Zbytek, et al. 2008 Current concepts of metastasis in melanoma Expert Rev Dermatol 3 569 585 19649148 1:CAS:528:DC%2BD1cXht12is7vF
6. AS Yang PB Chapman 2009 The history and future of chemotherapy for melanoma Hematol Oncol Clin North Am 23 583 597 19464604
7. A Breslow 1975 Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma Ann Surg 182 572 575 1190862 1:STN:280: DyaE28%2FmtVGkug%3D%3D
8. CM Balch, et al. 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648 11504745 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D (Pubitemid 32786276)
9. O Eton, et al. 1998 Prognostic factors for survival of patients treated systemically for disseminated melanoma J Clin Oncol 16 1103 1111 9508197 1:STN:280:DyaK1c7mslKhsA%3D%3D (Pubitemid 28108747)
10. AB Francken, et al. 2008 Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma Ann Surg Oncol 15 1476 1484 18196345
11. JF Thompson RA Scolyer RF Kefford 2009 Cutaneous melanoma in the era of molecular profiling Lancet 374 362 365 19647595
12. AD Singh, et al. 2004 The Zimmerman-McLean-Foster hypothesis: 25 years later Br J Ophthalmol 88 962 967 15205248 1:STN:280:DC%2BD2czgt1ejuw%3D%3D (Pubitemid 38869565)
13. RM White LI Zon 2008 Melanocytes in development, regeneration, and cancer Cell Stem Cell 3 242 252 18786412 1:CAS:528:DC%2BD1cXhtF2jtr7K
14. DL Roberts, et al. 2002 U.K. guidelines for the management of cutaneous melanoma Br J Dermatol 146 7 17 11841361 1:STN:280:DC%2BD387hslSgtQ%3D%3D (Pubitemid 34158403)
15. JS Michaelson, et al. 2005 Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism Br J Cancer 93 1244 1249 16278668 1:CAS:528:DC%2BD2MXht1ems7rK (Pubitemid 41679410)
16. RA Wascher, et al. 2003 Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccine J Clin Oncol 21 2558 2563 12829676 1:CAS:528:DC%2BD2cXptlCkt7s%3D (Pubitemid 46606338)
17. KS Hoek, et al. 2006 Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature Pigment Cell Res 19 290 302 16827748 1:CAS:528:DC%2BD28XpsVegsLo%3D (Pubitemid 44015592)
18. M Bockhorn RK Jain LL Munn 2007 Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8 444 448 17466902 1:CAS:528:DC%2BD2sXkslKru7k%3D (Pubitemid 46621773)
19. LL Chen, et al. 2009 Cancer metastasis networks and the prediction of progression patterns Br J Cancer 101 749 758 19707203 1:STN:280: DC%2BD1MrotVWmtA%3D%3D
20. TP Butler PM Gullino 1975 Quantitation of cell shedding into efferent blood of mammary adenocarcinoma Cancer Res 35 512 516 1090362 1:STN:280:DyaE2M7htVKiug%3D%3D
21. IJ Fidler, et al. 2002 The seed and soil hypothesis: vascularisation and brain metastases Lancet Oncol 3 53 57 11905606 1:CAS:528:DC%2BD38Xhtleitb0%3D (Pubitemid 34121146)
22. AC Chiang J Massague 2008 Molecular basis of metastasis N Engl J Med 359 2814 2823 19109576 1:CAS:528:DC%2BD1cXhsFCnt7bF
23. A Ulmer, et al. 2008 Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma Clin Cancer Res 14 4469 4474 18628461 1:CAS:528:DC%2BD1cXosFGit7c%3D
24. A Ulmer, et al. 2004 Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells Clin Cancer Res 10 531 537 14760074 1:CAS:528:DC%2BD2cXovVGrtQ%3D%3D (Pubitemid 38173991)
25. Y Husemann, et al. 2008 Systemic spread is an early step in breast cancer Cancer Cell 13 58 68 18167340 (Pubitemid 350309740)
26. S Mocellin, et al. 2006 The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis Clin Cancer Res 12 4605 4613 16899608 1:CAS:528:DC%2BD28XnvVGks7w%3D (Pubitemid 44297811)
27. I Sekine, et al. 2002 Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs Ann Oncol 13 1300 1306 12181255 1:STN:280:DC%2BD38visVCjsw%3D%3D (Pubitemid 34960140)
28. S Bhatia SS Tykodi JA Thompson 2009 Treatment of metastatic melanoma: an overview Oncol 23 488 496
29. Crosby T FR B Coles M Mason 2000 Systemic treatments for metastatic cutaneous melanoma Cochrane Database Syst Rev 2 CD001215
30. Richards JM BA, Gonzalez R, et al. (2005) High-dose Allovectin-7® in patients with advanced metastatic melanoma: final Phase 2 data and design of Phase 3 registration trial. J Clin Oncol 23:16s:7543
31. C Shepherd I Puzanov JA Sosman 2010 B-RAF inhibitors: an evolving role in the therapy of malignant melanoma Curr Oncol Rep 12 146 152 20425073 1:CAS:528:DC%2BC3cXht1CjsbzN
32. DE Fisher, et al. 2010 Melanoma from bench to bedside: meeting report from the 6th international melanoma congress Pigment Cell Melanoma Res 23 14 26 20025711 1:STN:280:DC%2BC3c%2FjtV2nuw%3D%3D
33. H Modjtahedi S Essapen 2009 Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities Anticancer Drugs 20 851 865 19826350 1:CAS:528:DC%2BD1MXht1GitrvM
34. KT Flaherty, et al. 2010 Inhibition of Mutated, Activated BRAF in Metastatic Melanoma N Engl J Med 363 809 819 20818844 1:CAS:528: DC%2BC3cXhtVyksb3M
35. A Mazzocca V Carloni 2009 The metastatic process: methodological advances and pharmacological challenges Curr Med Chem 16 1704 1717 19442141 1:CAS:528:DC%2BD1MXmslagtbs%3D
36. K Van Den Bossche JM Naeyaert J Lambert 2006 The quest for the mechanism of melanin transfer Traffic 7 769 778 (Pubitemid 43871769)
37. A Moustakas CH Heldin 2007 Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression Cancer Sci 98 1512 1520 17645776 1:CAS:528:DC%2BD2sXhtF2qtb7J (Pubitemid 47308444)
38. P Paterlini-Brechot NL Benali 2007 Circulating tumor cells (CTC) detection: clinical impact and future directions Cancer Lett 253 180 204 17314005 1:CAS:528:DC%2BD2sXnsFKqs7Y%3D (Pubitemid 47017533)
39. J Pouyssegur F Dayan NM Mazure 2006 Hypoxia signalling in cancer and approaches to enforce tumour regression Nature 441 437 443 16724055 1:CAS:528:DC%2BD28XkvVyrsr0%3D (Pubitemid 44050138)
40. T Kageshita, et al. 2001 Loss of beta-catenin expression associated with disease progression in malignant melanoma Br J Dermatol 145 210 216 11531781 1:STN:280:DC%2BD3MvptFOhtA%3D%3D (Pubitemid 32955344)
41. R Vogelmann, et al. 2005 TGFbeta-induced downregulation of E-cadherin-based cell-cell adhesion depends on PI3-kinase and PTEN J Cell Sci 118 4901 4912 16219695 1:CAS:528:DC%2BD2MXht1CnurrE (Pubitemid 41646396)
42. H Peinado F Portillo A Cano 2004 Transcriptional regulation of cadherins during development and carcinogenesis Int J Dev Biol 48 365 375 15349812 1:CAS:528:DC%2BD2cXhtVentLbL (Pubitemid 39360388)
43. MY Hsu, et al. 2000 E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors Am J Pathol 156 1515 1525 10793063 1:CAS:528:DC%2BD3cXjslKltLg%3D
44. V Sanz-Moreno, et al. 2008 Rac activation and inactivation control plasticity of tumor cell movement Cell 135 510 523 18984162 1:CAS:528: DC%2BD1cXhtlyqtr3N
45. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174 11990853 1:CAS:528: DC%2BD38Xis1KktL8%3D (Pubitemid 37328786)
46. CE Lewis JW Pollard 2006 Distinct role of macrophages in different tumor microenvironments Cancer Res 66 605 612 16423985 1:CAS:528: DC%2BD28XlsFOmtw%3D%3D (Pubitemid 43165918)
47. LA Liotta J Kleinerman GM Saidel 1974 Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation Cancer Res 34 997 1004 4841969 1:STN:280:DyaE2c3nsVamsg%3D%3D
48. GV Glinsky 1997 Apoptosis in metastatic cancer cells Crit Rev Oncol Hematol 25 175 186 9177940 1:STN:280:DyaK2szitFaiuw%3D%3D
49. MA Swartz, et al. 1999 Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity Br J Cancer 81 756 759 10555742 1:STN:280:DC%2BD3c%2Fit1Klug%3D%3D (Pubitemid 29504681)
50. CJ Larson, et al. 2004 Apoptosis of circulating tumor cells in prostate cancer patients Cytometry A 62 46 53 15472900 (Pubitemid 39473452)
51. G Mehes, et al. 2001 Circulating breast cancer cells are frequently apoptotic Am J Pathol 159 17 20 11438448 1:STN:280:DC%2BD3MzosVaitA%3D%3D (Pubitemid 33704186)
52. L Holmgren MS O'Reilly J Folkman 1995 Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1 149 153 7585012 1:CAS:528:DyaK2MXksVeru78%3D
53. DX Nguyen PD Bos J Massague 2009 Metastasis: from dissemination to organ-specific colonization Nat Rev Cancer 9 274 284 19308067 1:CAS:528:DC%2BD1MXjsFSrsr4%3D
54. L Borsig, et al. 2002 Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis Proc Natl Acad Sci USA 99 2193 2198 11854515 1:CAS:528:DC%2BD38XitVSrtL4%3D (Pubitemid 34169037)
55. H Laubli, et al. 2006 L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest Cancer Res 66 1536 1542 16452210 (Pubitemid 43259935)
56. MB Fuertes, et al. 2008 Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity J Immunol 180 4606 4614 18354183 1:CAS:528:DC%2BD1cXjsVKqsLk%3D
57. A Lacreusette, et al. 2007 Loss of oncostatin M receptor beta in metastatic melanoma cells Oncogene 26 881 892 16909117 1:CAS:528: DC%2BD2sXhsVersbc%3D
58. CE Horak, et al. 2008 The role of metastasis suppressor genes in metastatic dormancy APMIS 116 586 601 18834404 1:CAS:528:DC%2BD1cXht1Cjsb7L
59. J Eyles, et al. 2010 Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma J Clin Invest 120 2030 2039 20501944 1:CAS:528:DC%2BC3cXnt1KqtLY%3D
60. BA Yoshida, et al. 2000 Metastasis-suppressor genes: a review and perspective on an emerging field J Natl Cancer Inst 92 1717 1730 11058615 1:CAS:528:DC%2BD3cXot1SltL0%3D
61. M Röcken 2010 Early tumor dissemination, but late metastasis: insights into tumor dormancy J Clin Invest 120 1800 1803 20501952
62. JF Harms DR Welch ME Miele 2003 KISS1 metastasis suppression and emergent pathways Clin Exp Metastasis 20 11 18 12650602 1:CAS:528:DC%2BD3sXhsVWitLg%3D (Pubitemid 36308131)
63. M Boissan MF Poupon ML Lacombe 2007 NM23 and metastasis suppressor genes: update Med Sci (Paris) 23 1115 1123
64. PS Steeg CE Horak KD Miller 2008 Clinical-translational approaches to the Nm23-H1 metastasis suppressor Clin Cancer Res 14 5006 5012 18698018 1:CAS:528:DC%2BD1cXpslKgsbY%3D
65. S Gobeil, et al. 2008 A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene Genes Dev 22 2932 2940 18981472 1:CAS:528:DC%2BD1cXhtlOqtbnE
66. LA Shevde, et al. 2002 Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1 Exp Cell Res 273 229 239 11822878 1:CAS:528:DC%2BD38XovFKgtg%3D%3D (Pubitemid 34920673)
67. CC Lee, et al. 2008 Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma J Clin Oncol 26 535 541 18235114 (Pubitemid 351264345)
68. G Vijuk AS Coates 1998 Survival of patients with visceral metastatic melanoma from an occult primary lesion: a retrospective matched cohort study Ann Oncol 9 419 422 9636833 1:STN:280:DyaK1czgtVClsA%3D%3D (Pubitemid 28273035)
69. I Zalaudek, et al. 2003 Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities Br J Dermatol 148 703 708 12752127 1:STN:280:DC%2BD3s3jtVGnsQ%3D%3D (Pubitemid 36629748)
70. K Koyanagi, et al. 2005 Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial J Clin Oncol 23 8057 8064 16258104 (Pubitemid 46657408)
71. E Kujala T Mäkitie T Kivelä 2003 Very long-term prognosis of patients with malignant uveal melanoma Investig Ophthalmol Vis Sci 44 4651 4659 (Pubitemid 37315273)
72. JA Wargo K Tanabe 2009 Surgical management of melanoma Hematol Oncol Clin North Am 23 565 581 19464603
73. S Ramaswamy, et al. 2003 A molecular signature of metastasis in primary solid tumors Nat Genet 33 49 54 12469122 1:CAS:528:DC%2BD38XpvVeqs7w%3D (Pubitemid 36068681)
74. R Bernards RA Weinberg 2002 A progression puzzle Nature 418 823 12192390 1:CAS:528:DC%2BD38XmtlWlsLw%3D (Pubitemid 34966286)
75. C Waghorne, et al. 1988 Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations Cancer Res 48 6109 6114 3167857 1:STN:280:DyaL1M%2Fgt1Orug%3D%3D (Pubitemid 18266809)
76. D Fang, et al. 2005 A tumorigenic subpopulation with stem cell properties in melanomas Cancer Res 65 9328 9337 16230395 1:CAS:528:DC%2BD2MXhtFWmu7zI (Pubitemid 41508000)
77. JM Grichnik, et al. 2006 Melanoma, a tumor based on a mutant stem cell? J Invest Dermatol 126 142 153 16417230 1:CAS:528:DC%2BD28Xlt1Wju7s%3D (Pubitemid 43336106)
78. E Monzani, et al. 2007 Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential Eur J Cancer 43 935 946 17320377 1:CAS:528:DC%2BD2sXisleitLg%3D (Pubitemid 46366698)
79. T Schatton, et al. 2008 Identification of cells initiating human melanomas Nature 451 345 349 18202660 1:CAS:528:DC%2BD1cXnt1Gisg%3D%3D
80. SE Zabierowski M Herlyn 2008 Melanoma stem cells: the dark seed of melanoma J Clin Oncol 26 2890 2894 18539969
81. MS Wicha 2006 Cancer stem cells and metastasis: lethal seeds Clin Cancer Res 12 5606 5607 17020960 (Pubitemid 44629584)
82. K Pantel C Alix-Panabieres S Riethdorf 2009 Cancer micrometastases Nat Rev Clin Oncol 6 339 351 19399023 1:CAS:528:DC%2BD1MXms12gtbw%3D
83. GI Keshet, et al. 2008 MDR1 expression identifies human melanoma stem cells Biochem Biophys Res Commun 368 930 936 18279661 1:CAS:528: DC%2BD1cXjtVKltLg%3D
84. T Schatton MH Frank 2008 Cancer stem cells and human malignant melanoma Pigment Cell Melanoma Res 21 39 55 18353142 1:CAS:528:DC%2BD1cXkslKgsr8%3D (Pubitemid 351421465)
85. KS Smalley M Herlyn 2009 Integrating tumor-initiating cells into the paradigm for melanoma targeted therapy Int J Cancer 124 1245 1250 19089923 1:CAS:528:DC%2BD1MXisFGhu7Y%3D
86. AR Hess EA Seftor LM Gruman MS Kinch RE Seftor MJ Hendrix 2006 VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry Cancer Biol Ther 5 228 233 16481735 1:CAS:528:DC%2BD28XkvVOhtLo%3D (Pubitemid 43327544)
87. C La Porta 2009 Cancer stem cells: lessons from melanoma Stem Cell Rev 5 61 65 19093230 1:CAS:528:DC%2BD1MXmt1Sntbk%3D
88. A Roesch, et al. 2010 A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth Cell 141 583 594 20478252 1:CAS:528:DC%2BC3cXms1ehu7s%3D
89. KS Hoek CR Goding 2010 Cancer stem cells versus phenotype-switching in melanoma Pigment Cell Melanoma Res 23 746 759 20726948 1:CAS:528: DC%2BC3cXhsFanu7jE
90. DC Bennett 2008 How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 21 27 38 18353141 1:CAS:528: DC%2BD1cXkslKgsr4%3D (Pubitemid 351421467)
91. AK Bosserhoff 2006 Novel biomarkers in malignant melanoma Clin Chim Acta 367 28 35 16480699 1:CAS:528:DC%2BD28Xjs1Wqsrw%3D
92. H Gogas, et al. 2009 Biomarkers in melanoma Ann Oncol 20 Suppl 6 vi8 vi13 19617299
93. S Medic, et al. 2007 Molecular markers of circulating melanoma cells Pigment Cell Res 20 80 91 17371435 1:CAS:528:DC%2BD2sXltFKhu78%3D (Pubitemid 46439517)
94. K Koyanagi, et al. 2006 Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients Cancer Res 66 6111 6117 16778184 1:CAS:528:DC%2BD28XlvVSksLw%3D
95. L Xi, et al. 2007 Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers Clin Chem 53 1206 1215 17525108 1:CAS:528:DC%2BD2sXntlCqsb4%3D (Pubitemid 47020975)
96. K Koyanagi, et al. 2006 Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients Clin Cancer Res 12 1137 1143 16489066 1:CAS:528:DC%2BD28XhsFalt7s%3D (Pubitemid 43342501)
97. SR Alonso, et al. 2007 A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis Cancer Res 67 3450 3460 17409456 1:CAS:528:DC%2BD2sXksVGksbY%3D (Pubitemid 46724886)
98. S Mandruzzato, et al. 2006 A gene expression signature associated with survival in metastatic melanoma J Transl Med 4 50 17129373
99. D Talantov, et al. 2005 Novel genes associated with malignant melanoma but not benign melanocytic lesions Clin Cancer Res 11 7234 7242 16243793 1:CAS:528:DC%2BD2MXhtFartb3M (Pubitemid 41507680)
100. MG Tucci, et al. 2007 Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma Br J Dermatol 157 1212 1216 17970806 1:STN:280:DC%2BD2snosVykuw%3D%3D (Pubitemid 350115706)
101. A Kauffmann, et al. 2008 High expression of DNA repair pathways is associated with metastasis in melanoma patients Oncogene 27 565 573 17891185 1:CAS:528:DC%2BD1cXhtVKruro%3D (Pubitemid 351158908)
102. V Winnepenninckx, et al. 2006 Gene expression profiling of primary cutaneous melanoma and clinical outcome J Natl Cancer Inst 98 472 482 16595783 1:CAS:528:DC%2BD28Xjtlamt7c%3D
103. J Eberle, et al. 2008 Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma Exp Dermatol 17 1 11 18095940 1:CAS:528:DC%2BD1cXisVynsr8%3D (Pubitemid 350269205)
104. S Medic M Ziman 2009 PAX3 across the spectrum: from melanoblast to melanoma Crit Rev Biochem Mol Biol 44 85 97 19401874 1:CAS:528: DC%2BD1MXlslWhsr4%3D
105. JM Adams A Strasser 2008 Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res 68 4018 4021 18519656 1:CAS:528: DC%2BD1cXmsFKmtrc%3D
106. S Carreira, et al. 2006 Mitf regulation of Dia1 controls melanoma proliferation and invasiveness Genes Dev 20 3426 3439 17182868 1:CAS:528:DC%2BD2sXhs1ejsA%3D%3D (Pubitemid 44969160)
107. PB Gupta, et al. 2005 The evolving portrait of cancer metastasis Cold Spring Harb Symp Quant Biol 70 291 297 16869765 1:CAS:528:DC%2BD28XoslCgs7s%3D (Pubitemid 44124883)
108. L McArdle, et al. 2005 Microarray analysis of phosphatase gene expression in human melanoma Br J Dermatol 152 925 930 15888148 1:CAS:528: DC%2BD2MXlsFygs7s%3D (Pubitemid 40704932)
109. JM Topczewska, et al. 2006 Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness Nat Med 12 925 932 16892036 1:CAS:528:DC%2BD28Xnsl2iurk%3D (Pubitemid 44175144)
110. JD Kubic, et al. 2008 Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease Pigment Cell Melanoma Res 21 627 645 18983540 1:CAS:528:DC%2BD1MXmtleitg%3D%3D
111. D Lang, et al. 2005 Pax3 functions at a nodal point in melanocyte stem cell differentiation Nature 433 884 887 15729346 1:CAS:528:DC%2BD2MXhsFOrtbw%3D (Pubitemid 40314899)
112. RS Plummer, et al. 2008 PAX3 expression in primary melanomas and nevi Mod Pathol 21 525 530 18327212 1:CAS:528:DC%2BD1cXltVGksr0%3D (Pubitemid 351589648)
113. S Meng, et al. 2004 Circulating tumor cells in patients with breast cancer dormancy Clin Cancer Res 10 8152 8162 15623589 (Pubitemid 40053373)
114. JJ Cools-Lartigue, et al. 2008 Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines Mol Vis 14 50 55 18246031 1:CAS:528:DC%2BD1cXis1Gms7o%3D
115. E Quintana, et al. 2008 Efficient tumour formation by single human melanoma cells Nature 456 593 598 19052619 1:CAS:528:DC%2BD1cXhsVGlur7K
116. KD Lewis, et al. 2008 A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma Invest New Drugs 26 89 94 17891338 1:CAS:528:DC%2BD1cXlt1aqtA%3D%3D
117. M Tewes, et al. 2009 Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies Breast Cancer Res Treat 115 581 590 18679793
118. T Fehm, et al. 2008 Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance Breast Cancer Res 10 Suppl 1 S1 19091005
119. M Cristofanilli, et al. 2004 Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 351 781 791 15317891 1:CAS:528:DC%2BD2cXntVeitb4%3D (Pubitemid 39095313)
120. S Dawood M Cristofanilli 2007 Integrating circulating tumor cell assays into the management of breast cancer Curr Treatment Options Oncol 8 89 95